Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Cowley

Showing results (221-230 of 229) with videos related to

Pageof 23
Sort By:
You have reached the last page of results.This site can display upto 229 results.
Nature Communications|June 23, 2016
Integrated genetic and pharmacologic interrogation of rare cancersAndrew L Hong, Yuen-Yi Tseng, Glenn S Cowley, et al.
Scientific Data|May 19, 2015
Parallel genome-scale loss of function screens in 216 cancer cell lines for the identification of context-specific genetic dependenciesGlenn S Cowley, Barbara A Weir, Francisca Vazquez, et al.
Cell Systems|October 10, 2017
A Community Challenge for Inferring Genetic Predictors of Gene Essentialities through Analysis of a Functional Screen of Cancer Cell LinesMehmet Gönen, Barbara A Weir, Glenn S Cowley, et al.
Communications Biology|April 8, 2024
Targeting TRIP13 in favorable histology Wilms tumor with nuclear export inhibitors synergizes with doxorubicinKaruna Mittal, Garrett W Cooper, Benjamin P Lee, et al.
Cancer Discovery|May 30, 2013
Metabolic and functional genomic studies identify deoxythymidylate kinase as a target in LKB1-mutant lung cancerYan Liu, Kevin Marks, Glenn S Cowley, et al.
Blood|June 21, 2024
Preclinical efficacy of the potent, selective menin-KMT2A inhibitor JNJ-75276617 (bleximenib) in KMT2A- and NPM1-altered leukemiasMin Chul Kwon, Jan Willem Thuring, Olivier Querolle, et al.
Nature Genetics|April 25, 2017
Functional screen of MSI2 interactors identifies an essential role for SYNCRIP in myeloid leukemia stem cellsLy P Vu, Camila Prieto, Elianna M Amin, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 17, 2014
Complementary genomic approaches highlight the PI3K/mTOR pathway as a common vulnerability in osteosarcomaJennifer A Perry, Adam Kiezun, Peter Tonzi, et al.
Nature Communications|June 5, 2019
Neuronal differentiation and cell-cycle programs mediate response to BET-bromodomain inhibition in MYC-driven medulloblastomaPratiti Bandopadhayay, Federica Piccioni, Ryan O'Rourke, et al.
Pageof 23

Showing results (221-230 of 229) with videos related to

Sort By:
Pageof 23
You have reached the last page of results.This site can display upto 229 results.
Nature Communications|June 23, 2016
Integrated genetic and pharmacologic interrogation of rare cancersAndrew L Hong, Yuen-Yi Tseng, Glenn S Cowley, et al.
Scientific Data|May 19, 2015
Parallel genome-scale loss of function screens in 216 cancer cell lines for the identification of context-specific genetic dependenciesGlenn S Cowley, Barbara A Weir, Francisca Vazquez, et al.
Cell Systems|October 10, 2017
A Community Challenge for Inferring Genetic Predictors of Gene Essentialities through Analysis of a Functional Screen of Cancer Cell LinesMehmet Gönen, Barbara A Weir, Glenn S Cowley, et al.
Communications Biology|April 8, 2024
Targeting TRIP13 in favorable histology Wilms tumor with nuclear export inhibitors synergizes with doxorubicinKaruna Mittal, Garrett W Cooper, Benjamin P Lee, et al.
Cancer Discovery|May 30, 2013
Metabolic and functional genomic studies identify deoxythymidylate kinase as a target in LKB1-mutant lung cancerYan Liu, Kevin Marks, Glenn S Cowley, et al.
Blood|June 21, 2024
Preclinical efficacy of the potent, selective menin-KMT2A inhibitor JNJ-75276617 (bleximenib) in KMT2A- and NPM1-altered leukemiasMin Chul Kwon, Jan Willem Thuring, Olivier Querolle, et al.
Nature Genetics|April 25, 2017
Functional screen of MSI2 interactors identifies an essential role for SYNCRIP in myeloid leukemia stem cellsLy P Vu, Camila Prieto, Elianna M Amin, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 17, 2014
Complementary genomic approaches highlight the PI3K/mTOR pathway as a common vulnerability in osteosarcomaJennifer A Perry, Adam Kiezun, Peter Tonzi, et al.
Nature Communications|June 5, 2019
Neuronal differentiation and cell-cycle programs mediate response to BET-bromodomain inhibition in MYC-driven medulloblastomaPratiti Bandopadhayay, Federica Piccioni, Ryan O'Rourke, et al.
Pageof 23